
AnaptysBio ANAB
$ 59.97
3.97%
Annual report 2025
added 03-03-2026
AnaptysBio Current Ratio 2011-2026 | ANAB
Annual Current Ratio AnaptysBio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 12.8 | 19.9 | 17.9 | 10.2 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 19.9 | 10.2 | 15.2 |
Current Ratio of other stocks in the Biotechnology industry
| Issuer | Current Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
5.24 | $ 4.5 | 0.45 % | $ 862 M | ||
|
ADC Therapeutics SA
ADCT
|
1.2 | $ 3.83 | 1.32 % | $ 105 M | ||
|
Agenus
AGEN
|
0.708 | $ 3.64 | 9.31 % | $ 108 M | ||
|
Agios Pharmaceuticals
AGIO
|
12.5 | $ 35.08 | -0.36 % | $ 2.03 B | ||
|
Akebia Therapeutics
AKBA
|
1.09 | $ 1.39 | 0.36 % | $ 357 M | ||
|
Akari Therapeutics, Plc
AKTX
|
2.45 | $ 3.95 | -11.63 % | $ 266 B | ||
|
I-Mab
IMAB
|
8.96 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
0.922 | - | 2.54 % | $ 160 B | ||
|
Aldeyra Therapeutics
ALDX
|
2.59 | $ 1.57 | -5.42 % | $ 94.3 M | ||
|
Aligos Therapeutics
ALGS
|
2.53 | $ 8.08 | 1.38 % | $ 79.9 M | ||
|
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
1.19 | $ 331.14 | 3.85 % | $ 43.4 B | ||
|
Altimmune
ALT
|
5.09 | $ 3.4 | 1.8 % | $ 300 M | ||
|
ALX Oncology Holdings
ALXO
|
1.79 | $ 1.99 | 0.81 % | $ 107 M | ||
|
Amgen
AMGN
|
1.44 | $ 344.03 | -1.12 % | $ 185 B | ||
|
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | ||
|
Amneal Pharmaceuticals
AMRX
|
2.2 | $ 12.27 | -1.68 % | $ 3.85 B | ||
|
Anika Therapeutics
ANIK
|
14.4 | $ 14.99 | 1.28 % | $ 220 M | ||
|
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K | ||
|
ANI Pharmaceuticals
ANIP
|
1.5 | $ 73.8 | -0.55 % | $ 1.43 B | ||
|
Annexon
ANNX
|
4.21 | $ 5.56 | 1.0 % | $ 862 M | ||
|
Annovis Bio
ANVS
|
4.98 | $ 2.56 | 12.28 % | $ 52.6 M | ||
|
Adverum Biotechnologies
ADVM
|
1.65 | - | - | $ 86.2 M | ||
|
Advaxis
ADXS
|
5.93 | - | -9.65 % | $ 45.9 M | ||
|
Aptorum Group Limited
APM
|
3.71 | $ 0.88 | -5.16 % | $ 4.8 M | ||
|
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | ||
|
Aprea Therapeutics
APRE
|
6.02 | $ 0.7 | -1.87 % | $ 4.58 M | ||
|
Aquestive Therapeutics
AQST
|
0.827 | $ 4.12 | -0.24 % | $ 441 M | ||
|
Aeterna Zentaris
AEZS
|
1.6 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.995 | - | -10.17 % | $ 12.2 K | ||
|
AIkido Pharma
AIKI
|
2.59 | - | 1.93 % | $ 17.4 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
4.74 | $ 8.14 | 1.31 % | $ 223 M | ||
|
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | ||
|
Ardelyx
ARDX
|
1.5 | $ 5.99 | 0.84 % | $ 1.44 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | ||
|
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | ||
|
argenx SE
ARGX
|
6.39 | $ 749.99 | 0.48 % | $ 25 B | ||
|
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - | ||
|
Arcutis Biotherapeutics
ARQT
|
1.78 | $ 24.06 | 1.82 % | $ 3.06 B | ||
|
Arvinas
ARVN
|
2.53 | $ 10.87 | 0.14 % | $ 771 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
2.73 | $ 60.28 | -1.23 % | $ 8.06 B | ||
|
Allena Pharmaceuticals
ALNA
|
2.19 | - | 3.16 % | $ 1.9 M | ||
|
Assembly Biosciences
ASMB
|
5.07 | $ 29.51 | 1.72 % | $ 331 M | ||
|
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
3.34 | - | 10.36 % | $ 9.8 M | ||
|
Alterity Therapeutics Limited
ATHE
|
7.02 | $ 3.62 | 1.82 % | $ 8.71 B |